Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.9258 EUR
−8.84 M EUR
583.60 K EUR
5.23 M
About 4BASEBIO PLC ORD EUR1
Sector
Industry
CEO
Heikki Lanckriet
Website
Headquarters
Cambridge
Founded
2020
ISIN
GB00BMCLYF79
FIGI
4basebio Plc is a biotechnology company, which engages in the business of developing advanced therapy medicinal products through synthetic DNA products and non-viral, cell targeting nucleic acid delivery platforms. The firm is involved in manufacturing and supplying high quality synthetic DNA products for research, therapeutic, and pharmacological use; and developing target specific non-viral vectors for the efficient delivery of payloads in patients. The company was founded on December 22, 2020 and is headquartered in Cambridge, the United Kingdom.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on LSX exchange 4basebio PLC stocks are traded under the ticker A3CWA4.
A3CWA4 stock has fallen by −4.29% compared to the previous week, the month change is a −4.29% fall, over the last year 4basebio PLC has showed a −4.29% decrease.
A3CWA4 stock is 6.87% volatile and has beta coefficient of 0.21. Track 4basebio PLC stock price on the chart and check out the list of the most volatile stocks — is 4basebio PLC there?
Yes, you can track 4basebio PLC financials in yearly and quarterly reports right on TradingView.
4basebio PLC is going to release the next earnings report on May 7, 2025. Keep track of upcoming events with our Earnings Calendar.
A3CWA4 net income for the last half-year is −6.76 M EUR, while the previous report showed −4.74 M EUR of net income which accounts for −42.63% change. Track more 4basebio PLC financial stats to get the full picture.
No, A3CWA4 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jan 16, 2025, the company has 84.00 employees. See our rating of the largest employees — is 4basebio PLC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. 4basebio PLC EBITDA is −8.89 M EUR, and current EBITDA margin is −1.25 K%. See more stats in 4basebio PLC financial statements.
Like other stocks, A3CWA4 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade 4basebio PLC stock right from TradingView charts — choose your broker and connect to your account.